- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rebif®
Total 13787 results
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Relapsing-RemittingSweden, Germany
-
EMD SeronoCompletedMultiple SclerosisItaly, Russian Federation, United States, Argentina, Venezuela, Canada, Tunisia, France
-
Merck KGaA, Darmstadt, GermanyEMD Serono Canada Inc.CompletedClinically Isolated SyndromeCanada
-
Waukesha Memorial HospitalThe Cleveland ClinicCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
EMD SeronoMerck Serono International SACompletedMultiple Sclerosis, Relapsing-remitting
-
EMD SeronoCompleted12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.Multiple SclerosisUnited States, Canada, Germany, Italy, Spain, Sweden
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisGermany, Estonia, Latvia, Lithuania, Finland, Austria, Denmark, Netherlands, Portugal, Switzerland, Norway, Italy
-
EMD SeronoMerck Serono International SACompletedMultiple Sclerosis, Relapsing-Remitting
-
German University in CairoRecruiting
-
EMD Serono Research & Development Institute, Inc.CompletedMultiple SclerosisLebanon, United States, Turkey, Sweden, Finland, France, Thailand, Serbia, Italy, United Kingdom, United Arab Emirates, Bulgaria, Belgium, Estonia, Argentina, Austria, Bosnia and Herzegovina, Canada, Croatia, Czechia, Georgia, Ger... and more
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
EMD SeronoCompletedMultiple SclerosisUnited States
-
EMD SeronoWithdrawnRelapsing-Remitting Multiple Sclerosis
-
Merck KGaA, Darmstadt, GermanyMerck B.V., NetherlandsTerminated
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Clinically Isolated SyndromeCroatia, Bulgaria, France, Italy, Russian Federation, Spain, Estonia, Germany, Latvia, Poland, Romania, Argentina, Finland, Israel, Greece, Czech Republic, Slovakia, Austria, Belgium, Canada, Lebanon, Morocco, Portugal, Serbia
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisItaly
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisUnited States, Canada, Puerto Rico
-
EMD SeronoCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
EMD SeronoCompletedRelapsing Multiple SclerosisUnited States
-
University of North Carolina, Chapel HillCompletedMultiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyMerck spol.s.r.o., Czech RepublicCompletedMultiple Sclerosis, Relapsing-RemittingCzech Republic
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbHCompleted
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbHCompleted
-
Merck KGaA, Darmstadt, GermanyMerck Serono Australia Pty LtdCompleted
-
BiogenCompleted
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.P.A., ItalyCompleted
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisKorea, Republic of
-
Teva Neuroscience, Inc.Completed
-
EMD SeronoTerminatedMultiple SclerosisUnited States
-
SanofiCompletedMultiple SclerosisGermany, Ukraine, Canada, Austria, Russian Federation
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden and other collaboratorsCompletedMultiple Sclerosis, Relapsing RemittingGreece
-
PD Dr. Marcus MüllerBfARM, Bonn; DZNE, BonnUnknownRelapsing-remitting Multiple SclerosisGermany
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, France, United States, Germany, Canada, United Kingdom, Russian Federation, Argentina, Brazil, Croatia, Poland, Serbia, Sweden, Ukraine, Czech Republic, Mexico
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-Remitting
-
Washington University School of MedicineNational Institute on Disability, Independent Living, and Rehabilitation...Active, not recruiting
-
Merck KGaA, Darmstadt, GermanyMerck Serono Limited, UKCompletedRelapsing Multiple SclerosisUnited Kingdom
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Russian Federation, Poland, Croatia, United Kingdom
-
EMD SeronoMerck Serono International SACompletedUlcerative ColitisSweden, Germany, Netherlands, Israel, Singapore, Switzerland, United Kingdom
-
SanofiCompletedMultiple SclerosisUnited States, Canada, Germany, Spain, Italy
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, Denmark, Canada, United States, Netherlands, Argentina, Austria, Belgium, Brazil, Croatia, Czech Republic, France, Germany, Israel, Italy, Mexico, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine, United Kingdom
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing Remitting Multiple Sclerosis
-
IMS HEALTH GmbH & Co. OHGEMD SeronoCompletedRelapsing-remitting Multiple SclerosisUnited States, Canada
-
Aaron BosterPfizer; EMD SeronoCompleted
-
BayerCompletedRelapsing-remitting Multiple SclerosisFrance
-
Melinda MagyariUniversity of CopenhagenCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisCroatia, Bulgaria, France, Italy, Russian Federation, Spain, Turkey, Estonia, Germany, Latvia, Poland, Romania, Argentina, Israel, Portugal, Greece, Czech Republic, Slovakia, Serbia, Austria, Finland, Saudi Arabia, Belgium, Canada, Lebanon and more
-
SanofiCompletedMultiple SclerosisUnited States, Canada, Germany, Italy, Spain, United Kingdom, Austria